In 2009, PNG disbursed DSIP funds of US$1.6 million per MP (K4.5 million), leaving it second only to the Philippines (US$4.3 million) when compared to the countries included in one major international report
But this is anecdotal, and selection bias, those willing to try a newer, less proven compound tend to be more experienced and disciplined, could account for better reported outcomes
Reach your goals with Shotsy the full-featured tracker for GLP-1 medications like Ozempic, Wegovy, Mounjaro, Zepbound, Semaglutide, and Tirzepatide
Transparent, upfront pricing with no hidden fees.
Oral GLP-1 Drugs in China: Market Entry and Development Outlook Compared with Europe and the United States, the oral GLP-1 weight-loss drug market in China is still in its early development stage
Human Research Limitations Human research specifically examining exogenous IGF-1 LR3 administration is remarkably limited in peer-reviewed scientific literature - searches of PubMed and other databases yield virtually no controlled clinical trials for any indication
